This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: Takeda Pharmaceuticals U.s.a., Inc., Zinfandel Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. Active years: 2013-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 24 
3 out of 8 
2 out of 1,228 
Years Active: 2013-2021
Title: Innovative Contributions of Rajneesh Taneja in Alzheimer's Research
Introduction
Rajneesh Taneja, a prominent inventor located in Libertyville, IL, has made significant strides in the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. With a total of eight patents to his name, Taneja's work embodies a commitment to advancing medical science and improving the quality of life for those affected by neurodegenerative conditions.
Latest Patents
Among his recent innovations, Taneja has developed methods and drug products aimed at treating Alzheimer's disease. His patent details drug products containing low doses of pioglitazone, which are designed to delay the onset of cognitive impairment associated with Alzheimer's. Furthermore, Taneja's methods include assessing the patient’s risk for developing the disease based on their age and specific genetic markers (TOMM40 523 genotype). Another notable patent involves modified release dosage forms of xanthine oxidoreductase inhibitors, showcasing his versatility in addressing various therapeutic areas.
Career Highlights
Throughout his career, Rajneesh Taneja has worked with reputable organizations, including Takeda Pharmaceuticals USA, Inc. and Zinfandel Pharmaceuticals, Inc. These experiences have not only enriched his knowledge but have also provided a platform for his groundbreaking research and inventions.
Collaborations
Taneja's incredible journey has seen important collaborations with notable peers in the industry, including Majid Vakilynejad and Allen D. Roses. These partnerships highlight the value of teamwork in the pursuit of innovation and progress in the pharmaceutical landscape.
Conclusion
Rajneesh Taneja's dedication to research and innovation has produced significant patents that contribute to the understanding and treatment of Alzheimer's disease. His commitment to improving patient outcomes through novel drug formulations solidifies his position as a key figure in the realm of pharmaceutical inventions. As research continues, Taneja's contributions will undoubtedly inspire further advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile